$ Value
$46K
Shares
7,205
Price
$6
Filed
Feb 6
Insider
Name
Ganot Ilan
Title
—
CIK
0001727460
Roles
Transaction Details
Transaction Date
2026-02-04
Code
S
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
25,271
Footnotes
This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. | Represents 95,255 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship. | Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.
Filing Info
Ganot Ilan's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-18 | SLDB | ▼ | $15K |
| 2026-02-13 | SLDB | M | — |
| 2026-02-13 | SLDB | M | $0 |
| 2026-02-04 | SLDB | ▼ | $46K |
| 2026-01-31 | SLDB | M | — |
| 2026-01-31 | SLDB | M | $0 |
| 2026-01-29 | SLDB | A | $0 |
| 2026-01-29 | SLDB | A | $0 |
| 2026-01-28 | SLDB | ▼ | $1K |
| 2026-01-27 | SLDB | M | — |
Other Insiders at SLDB (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| SMITH IAN F | — | — | 2026-04-02 |
|
Howton David T
Chief Operating Officer
|
— | $408K | 2026-02-18 |
|
Cumbo Alexander
President and CEO
|
— | $929K | 2026-02-18 |
| Ganot Ilan | — | $17K | 2026-02-18 |
|
Tan Kevin
CFO & Treasurer
|
— | $299K | 2026-02-18 |
|
Hanrahan Jessie
Chief Regulatory Officer
|
— | $274K | 2026-02-18 |
|
Herzich Paul
Chief Technology Officer
|
— | $260K | 2026-02-18 |
|
Brooks Gabriel
Chief Medical Officer
|
— | $264K | 2026-02-18 |